We: Use only pharmaceutical-grade, synthetic peptides from verified sources Conduct thorough health assessments before recommending any peptide therapy Keep a watchful eye for adverse reactions Adjust your protocol based on your individual response Stay current with emerging research and safety data Risk/Benefit Checklist Before starting peptide therapy, take time to consider: Your current health statuscertain conditions may make specific peptides a poor fit for you
Expert Opinion on Biological Therapy , 12 (1), 3751
Domestic shipping: EU UK USA AU 57 days International shipping: 714 days 77 publications found Last 10 years 3 most recent shown Source: PubMed / NCBI Last 10 years Refreshed every 24 hours For research reference only not clinical guidance
Availability: 64 in stock Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys (1) Molecular Formula: C 50 H 68 N 14 O 10 Molecular Weight: 1025.182 g/mol PubChem CID: 9941379 CAS Number: 189691-06-3 Monoisotopic Mass: 1024.52428442 Polar Area: 379 Complexity: 1950 XLogP: 0.7 Heavy Atom Count: 74 Hydrogen Bond Donor Count: 13 Hydrogen Bond Acceptor Count: 12 Rotatable bond count: 17 Pubchem LCSS : Bremelanotide Laboratory Chemical Safety Summary PT-141 has been investigated for its role in centrally mediated sexual arousal pathways , primarily through activation of melanocortin receptors, with particular emphasis on MC4R signaling within hypothalamic and limbic circuits involved in motivational behavior [1,2]
Your practitioner will recommend a schedule based on your health goals.
